Sandoz Group AG (SDZNY)

OTCMKTS · Delayed Price · Currency is USD

52.66

-0.76 (-1.42%)

Jun 24, 2025, 3:55 PM EDT

Sandoz Group AG Employees

Sandoz Group AG had 22,049 employees as of December 31, 2024. The number of employees decreased by 584 or -2.58% compared to the previous year.

Employees

22,049

Change (1Y)

-584

Growth (1Y)

-2.58%

Revenue / Employee

$470,951

Profits / Employee

n/a

Market Cap

22.65B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	22,049	-584	-2.58%
Dec 31, 2023	22,633	895	4.12%
Dec 31, 2022	21,738	-	-

Related Stocks

Company Name	Employees
Endo, Inc.	3,116
Elite Pharmaceuticals	64
Tian'an Technology Group	8
American Oncology Network	1,914
Glass House Brands	374
CytoDyn	9
Northwest Biotherapeutics	25
Silence Therapeutics	116

Employee Rankings

Sandoz Group AG News

8 days ago - Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee - Fortune
8 days ago - Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor - Benzinga
23 days ago - Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] - GlobeNewsWire
4 weeks ago - Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars - GlobeNewsWire
7 weeks ago - Sandoz Group AG (SDZNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
2 months ago - Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed - GlobeNewsWire
2 months ago - Sandoz inks agreement with Shanghai Henlius for Bristol Yervoy biosimilar - Seeking Alpha
2 months ago - Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications - GlobeNewsWire